In brief: Aptiva closes CGM deal, NHIA warns of bid impact, VGM Forbin adds services

FORT LAUDERDALE, Fla. – Aptiva Medical, a provider of continuous glucose monitoring (CGM) systems and a portfolio company of Greenleaf Ventures, has completed its acquisition of VeraMed Health. 

The company says the transaction significantly expands its patient base, strengthens its referral and payer networks, and accelerates its rapid growth – further reinforcing its leadership in delivering advanced diabetes management solutions to patients across the country. 

"This acquisition aligns perfectly with Aptiva Medical's mission to build a leading, nationwide direct-to-patient CGM business," said David Wallace, co-founder and managing partner of Greenleaf Ventures. "The VeraMed team has built an excellent foundation of patient care, and Aptiva Medical will ensure a seamless transition for every patient while continuing to raise the bar on service and efficiency." 

Wallace and Timothy Stocksdale, co-founder of Greenleaf Ventures, have a long track record of building and scaling successful health care companies in the medical supply and pharmacy sectors, including Access Diabetic Supply, Arriva Medical, Comfort Medical, and AmerimedRx. In 2014, they acquired Liberty Medical out of bankruptcy and restructured it, later selling it to Cardinal Health. 

NHIA white paper outlines negative impact of competitive bidding on home enteral nutrition 

ALEXANDRIA, Va. – The National Home Infusion Association (NHIA) has released a new white paper, “Trends in Home Enteral Nutrition—The Impacts of Competitive Bidding on Access and Quality,” that documents the declining payment structure for the clinical services needed to support patients on this therapy.  

An estimated 220,000 individuals in the United States rely on home enteral nutrition (HEN), a therapy that demands clinical coordination, specialized equipment, disease-specific nutrition formulas, and a multidisciplinary team to ensure safety, efficacy and quality of life, the NHIA says. 

The impact of competitive bidding and other payer policies 

Although government reports say that competitive bidding has not negatively impacted access to HEN, NHIA reviewed publicly available Medicare DME utilization data and found the number of suppliers billing for HEN kits has decreased by 31% over the past decade, while the number of Medicare beneficiaries accessing HEN has declined by 27%. 

The association says the market conditions created by competitive bidding may also influence other payer policies. One in four HEN providers are considering or planning to discontinue providing HEN formulas or supplies due to cost pressures, according to reports. 

NHIA recommends reforms 

NHIA believes that certain reforms would improve outcomes and the quality of life in HEN patients, while lowering the total cost of care. It recommends that CMS: 

• Perform a comprehensive study of HEN services, patient access and impacts on overall costs of care; 
• Develop new supplier standards to reflect clinical support expectations and standardized outcomes; and 
• Develop a new service code for clinical activities such as performing nutritional assessments, monitoring nutritional status, making formula changes, troubleshooting problems and providing nutrition education and support. 

Read the white paper. 

VGM Forbin adds Salesforce implementation, AI training to tech offerings 

WATERLOO, Iowa – VGM Forbin, a division of VGM Group, has launched two new technology offerings: Salesforce implementation, and artificial intelligence (AI) training and agent development. These new services are the result of a recent merger with Redstone Content Solutions, also part of VGM. "We are thrilled to introduce AI training and Salesforce implementation to our suite of services,” said VGM Forbin President Cassi Price. “The teams at Redstone and Forbin have been collaborating on multiple projects for much of the past year. Formally combining these two incredible teams allows us to further expand our expertise and make VGM Forbin the top choice for technology solutions in the industries we serve.” VGM Forbin offers a host of technology services ranging from website development and digital marketing to managed IT/security and compliance programs. It serves customers in a variety of markets but specializes in the financial and health care industries. "VGM Group is continuously adding new ways to expand our offerings and help our customers scale their businesses,” said CEO Jeremy Stolz. “This merger increases the collaboration between two of VGM’s top teams of technology experts. This not only broadens our service offerings but also reinforces our commitment to delivering top-tier solutions to our customers.”  

Soleo Health recognized as ‘Pioneer’ for SoleMetrics program 

FRISCO, Texas – Soleo Health has announced that it is a Specialty Pharmacy Pioneer recipient of URAC’s 2024 Leaders in Performance Measurement Awards Program. Through its Leaders in Performance Measurement (LPM) program, URAC, a non-profit organization that provides accreditation and certification for health care organizations, recognizes companies that demonstrate a commitment to improving health care quality through performance measurement. Soleo Health was recognized for its dedication and commitment to providing quality patient outcomes data through its proprietary SoleMetrics outcomes program. “For the LPM program, Soleo Health provided URAC with therapeutic care management team performance, such as clinical interventions, accuracy of dispensing activities, and patient satisfaction, which all exceeded specialty measurement benchmarks,” said Lisa Siefert, RPh, vice president, clinical services and quality for Soleo Health. 

AOPA redesigns, relaunches website 

ALEXANDRIA, Va. – The American Orthotic & Prosthetic Association (AOPA) has launched a totally revamped website featuring a cleaner, faster, more modern intuitive design with more opportunities to better highlight members, the association says. All employees of member organizations can access resources via the Co-OP, compared to previous one-license-per-company limits. The website features easy to find information on advocacy, coding and reimbursement updates and resources, and education and events. Access the site at https://aopanet.org/. 

NCPA launches pilot with Bristol Myers Squibb to address cardiovascular disease in rural communities 

ALEXANDRIA, Va. – The National Community Pharmacists Association (NCPA) has launched a partnership with Bristol Myers Squibb to address health-related social needs and care coordination for patients with cardiovascular disease (CVD). The two organizations are piloting specialized training for pharmacy technicians in community health. “We are pleased to partner with BMS to improve access to care for people in rural communities,” said B. Douglas Hoey, pharmacist, CEO of NCPA. “The NCPA Innovation Center has partnered with the 25 rural pharmacies to improve cardiovascular outcomes through care coordination, screenings, transition of care interventions, and making sure patients have access to the medicines they need to sustain and improve health. Community pharmacists and their teams are increasingly playing a bigger role in the health care of Americans, and we are excited to create new, sustainable models of pharmacy-based care.” Pharmacist-community health worker teams in 25 rural pharmacies across Alabama, Arkansas, Kentucky, Louisiana, Mississippi and Missouri will be trained through a rigorous curriculum to more effectively evaluate patients with higher risk of CVD and guide them toward appropriate health care providers for further care and evaluation. Additionally, NCPA is creating new access points at these same independent pharmacies for screening, monitoring and management of cardiovascular disease, funded through a separate and independent grant by BMS, as part of a pilot program to evaluate the impact of enhanced access to critical health care services in medically underserved communities. 

Trividia issues voluntary recall of True Metrix meters 

FORT LAUDERDALE, Fla. – Trividia Health is voluntarily recalling a limited number of True Metrix Self-Monitoring blood glucose meters co-branded under the Good Neighbor Pharmacy brand and distributed in the United States. The company has determined that 601 True Metrix meters, lot number KD0746, manufactured Sept. 4, 2025, and distributed Sept. 8, 2025, through Sept. 16, 2025, may have the potential for defective LCD displays that can affect product performance, such as showing partial or missing numerical segments or characters or showing ghosting (fading) of numerical segments or characters. As a result, it is possible that users could misinterpret a test result or experience a delay in obtaining test results. For users with low glucose (hypoglycemia), this could result in a delay in treatment or therapy decisions. Trividia Health has not received any reports of patient injuries related to this voluntary recall. Consumers who believe they have affected product can confirm in one of the following ways: 

• Call Trividia Health Customer Care Department toll-free at 1-888-835-2723 Monday-Friday 8AM-8PM EST (excluding holidays). 
• Contact the company via email at trividia0925CC@trividiahealth.com. 
• Check the lot number (KD0746) printed on the side of the product’s box. 
• Visit www.trividiahealth.com/productnotice for a quick search using the meter’s serial number.